Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44381 clinical trials with a EudraCT protocol, of which 7393 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (10,987)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

10,987 result(s) found. Displaying page 211 of 550.

EudraCT Number: 2009-014387-20

Sponsor Protocol Number: DORI-PED-1003

Start Date*: 2009-10-23

Sponsor Name:Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium

Full Title: An Open-Label Study to Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants (Term and Preterm), Less Than 12 Weeks Chronological Age Protocol DORI-PED-1003;...

Medical condition: hospitalized but medically stable infants (term and preterm), <12 weeks CA, who have documented, presumed to have, or are at risk for bacterial infection(s) and are undergoing treatment with i.v. a...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10004044	Bacterial infection NOS	LLT

Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: BE (Completed) GB (Completed) Outside EU/EEA

Trial results: View results

EudraCT Number: 2010-018851-88

Sponsor Protocol Number: IPR/23

Start Date*: 2010-09-27

Sponsor Name:MOLMED

Full Title: NGR016: Randomized phase II study evaluating two doses of NGR-hTNF administered either as single agent or in combination with doxorubicin in patients with advanced soft-tissue sarcoma (STS).

Medical condition: Locally advanced or metastatic STS patients untreated or previously treated with one or more prior systemic regimen.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10041299		HLGT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2008-005305-19

Sponsor Protocol Number: D5130C00030

Start Date*: 2008-11-17

Sponsor Name:AstraZeneca AB

Full Title: A Randomised, Double-Blind, Outpatient, Crossover Study of the Anti-platelet Effects of AZD6140 Compared with Clopidogrel in Patients with Stable Coronary Artery Disease Previuosly Identified as Cl...

Medical condition: Stable Coronary Artery Disease AZD6140 is under development for the prevention of thrombotic events in patients with non-ST and ST elevation coronary syndromes

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10011085	Ischaemic coronary artery disorders	HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2005-002421-31

Sponsor Protocol Number: P-AD452-022

Start Date*: 2005-09-16

Sponsor Name:Arakis Ltd

Full Title: A phase II randomized, double-blind, multicentre, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of 3 strengths of AD 452 in adult subjects ...

Medical condition: Rheumatoid arthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:			10039073		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed)

Trial results: (No results available)

EudraCT Number: 2004-001580-22	Sponsor Protocol Number: 062	Start Date*: 2004-12-21
Sponsor Name:MSD SHARP & DOHME GMBH
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Adding Ezetimibe 30 mg to an Ongoing Regimen of Ezetimibe 10 mg in Patients With Homozygous Sito...
Medical condition: Homozygous Sitosterolemia
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Completed) GB (Completed)
Trial results: View results

EudraCT Number: 2004-005071-42	Sponsor Protocol Number: CERL080AGB03	Start Date*: 2005-05-06
Sponsor Name:Novartis Pharmaceuticals UK Limited
Full Title: A study of the effect of conversion to Myfortic on quality of life in patients with gastrointestinal (GI) symptoms related to MMF therapy after renal transplantation (MYQOL).
Medical condition: Renal transplantation
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: IE (Completed) GB (Completed)
Trial results: View results

EudraCT Number: 2004-002530-20	Sponsor Protocol Number: GWCL0305	Start Date*: 2005-04-29
Sponsor Name:GW Pharma Ltd
Full Title: A double blind, randomised, placebo controlled, parallel group study of Sativex in the treratment of subjects with pain due to diabetic neuropathy
Medical condition: Painful diabetic neuropathy
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: GB (Completed) CZ (Completed)
Trial results: View results

EudraCT Number: 2005-000941-12	Sponsor Protocol Number: BAY 43-9006 / 11718	Start Date*: 2005-08-18
Sponsor Name:Onyx Pharmaceuticals, Inc.
Full Title: Phase III randomised, placebo controlled study of sorafenib in repeated cycles of 21 days in combination with paclitaxel/carboplatin chemotherapy in subjects with unresectable stage III or stage IV...
Medical condition: unresectable, advanced Stage III or Stage IV melanoma
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: GB (Completed) DE (Completed)
Trial results: View results

EudraCT Number: 2005-003349-15

Sponsor Protocol Number: ARPH-CL-03

Start Date*: 2006-02-07

Sponsor Name:Ariston Pharmaceuticals, Inc

Full Title: Intranasal Hydroxocobalamin (AST-726) Treatment for Prohylaxis of Migraine: a Placebo-Controlled, Clinical Study

Medical condition: Migraine headache with and without aura

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10058734	Migraine prophylaxis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed) GB (Completed)

Trial results: (No results available)

EudraCT Number: 2005-003145-13

Sponsor Protocol Number: TMC125-C206

Start Date*: 2006-07-06

Sponsor Name:Tibotec Pharmaceuticals Limited

Full Title: A Phase III randomized, double-blinded, placebo-controlled trial to investigate the efficacy, tolerability and safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected O...

Medical condition: HIV-1 infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.0		10020192		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2005-004383-23	Sponsor Protocol Number: RISSCH4055	Start Date*: 2005-11-24
Sponsor Name:Janssen Cilag Ltd
Full Title: Pragmatic randomized trial of Risperdal Consta versus oral atypical antipsychotics in poorly adherent subjects with schizophrenia ina routine care setting. Protocol RISSCH4055; Phase IV (risperid...
Medical condition: Schizophrenia
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: GB (Completed) IE (Prematurely Ended)
Trial results: View results

EudraCT Number: 2009-016973-13

Sponsor Protocol Number: LX1606.1-203-CS

Start Date*: 2010-03-08

Sponsor Name:Lexicon Pharmaceuticals, Inc

Full Title: A Phase 2, Open-Label, Multi-Center, Serial Ascending-Dose, Dose Finding Study to Evaluate the Safety and Tolerability of LX1606 in Subjects with Symptomatic Carcinoid Syndrome

Medical condition: Symptomatic Carcinoid Syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	15.1	10014698 - Endocrine disorders	10007270	Carcinoid syndrome	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2008-007978-38

Sponsor Protocol Number: V3381-2DPNP-02

Start Date*: 2009-02-12

Sponsor Name:Vernalis (R & D) Limited

Full Title: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Parallel Group Study of the Safety, Tolerability and Efficacy of V3381 for Up to 13 Weeks in Patients with Diabetic Peripheral Neuropath...

Medical condition: Diabetic Peripheral Neuropathic Pain (DPNP)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10012683	Diabetic peripheral neuropathy	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) CZ (Completed)

Trial results: (No results available)

EudraCT Number: 2005-002678-31

Sponsor Protocol Number: CA184-007

Start Date*: 2006-03-20

Sponsor Name:BRISTOL-M.SQUIBB

Full Title: Randomized, double-blind, placebo controlled phase II study comparing the safety of MDX-010 BMS-734016 administered with or without prophylactic oral budesonide Entocort EC in patients with unr...

Medical condition: Melanoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	6.1		10027156		HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2011-000164-10

Sponsor Protocol Number: SPD476-112

Start Date*: 2013-01-04

Sponsor Name:Shire Development LLC

Full Title: A Phase 1, Multicenter, Open-label Study to Determine the Safety and Pharmacokinetics of MMX Mesalamine Following Administration in Children and Adolescents With Ulcerative Colitis

Medical condition: Ulcerative Colitis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004856	10045365	Ulcerative colitis	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: GB (Completed) SK (Completed)

Trial results: View results

EudraCT Number: 2015-005550-35

Sponsor Protocol Number: CCD-06001AA1-10

Start Date*: 2016-09-26

Sponsor Name:Chiesi Farmaceutici S.p.A.

Full Title: A RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED, REPEATED DOSE, THREE-WAY CROSSOVER STUDY TO EVALUATE THE PHARMACODYNAMICS, PHARMACOKINETICS AND SAFETY OF TWO DOSES OF CHF 6001 DPI IN SUBJECTS WITH ...

Medical condition: COPD

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	19.0	100000004855	10010952	COPD	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2006-003615-40	Sponsor Protocol Number: NBS-C03-OP	Start Date*: 2006-10-10
Sponsor Name:Osteologix A/S
Full Title: A dose-response study with stronitum malonate in postmenopausal women. 12 week, multinational, double-blind, randomised, 5 arms, parallel group placebo controlled, open label active controlled, ph...
Medical condition: postmenopausal osteoporosis
Disease:
Population Age: Adults, Elderly		Gender: Female
Trial protocol: DK (Completed) GB (Completed)
Trial results: (No results available)

EudraCT Number: 2006-001062-17

Sponsor Protocol Number: ASF-1096-201/250912BS

Start Date*: 2006-11-30

Sponsor Name:Astion Danmark A/S

Full Title: Efficacy and safety of ASF-1096 cream 0.5% in the treatment of patients with newly developed discoid lupus erythymatosus (DLE) lesions. A multi centre clinical phase 2, placebo controlled and doubl...

Medical condition: Male or female patients with a clinical diagnosis of either Discoid Lupus Erythmatosus or Systemic Lupus Erythmatosus and at least one newly developed, sharply demarcated DLE lesion.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10025138	Lupus erythematosus discoides	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) SE (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2005-004487-22

Sponsor Protocol Number: BMI 001 / SMR-1389

Start Date*: 2005-11-25

Sponsor Name:Bio-Medisinsk Innovasjon AS

Full Title: A Proof of Biological Efficacy Study Assessing the Potential of Piboserod a Specific 5-HT4 Antagonist for the Treatment of Symptomatic Congestive Heart Failure in stable outpatients NYHA class II-I...

Medical condition: Congestive heart failure

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	4.0		10010684		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed) GB (Completed)

Trial results: (No results available)

EudraCT Number: 2006-004785-14

Sponsor Protocol Number: CNF1340-SCLC-002

Start Date*: 2007-04-03

Sponsor Name:Celgene Corporation

Full Title: A Phase II Trial of Single-Agent Amrubicin in Patients with Extensive Disease Small Cell Lung Cancer that is Refractory or Progressive within 90 Days of Completion of First-Line Platinum-based Chem...

Medical condition: Extensive Disease Small Cell Lung Cancer that is refractory or progressive

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10041068	Small cell lung cancer extensive stage	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) NL (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Fri Feb 13 20:49:01 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA